Article
The Role of Pharmacogenetics in Personalizing the Antidepressant and Anxiolytic Therapy
16 May 2023
Abstract excerpt
Pharmacotherapy for neuropsychiatric disorders, such as anxiety and depression, has been characterized by significant inter-individual variability in drug response and the development of side effects. Pharmacogenetics, as a key part of personalized medicine, aims to optimize therapy according to a patient's individual genetic signature by targeting genetic variations involved in pharmacokinetic or pharmacodynamic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
